Your browser doesn't support javascript.
loading
Expression of MLAA34-HSP70 fusion gene constructed by SOE-PCR
Pakistan Journal of Pharmaceutical Sciences. 2017; 30 (3 [Special]): 1125-1127
en Inglés | IMEMR | ID: emr-189323
ABSTRACT
To construct the pIRES2-MLAA34-HSP70 recombinant vector and express the MLAA34-HSP70 recombinant proteins in Escherichia coli [E. coli]. The MLAA34 and the HSP70 genes were extracted from U937 cells by RT-PCR, and then we amplified the fusion gene MLAA34-HSP70 by SOE-PCR and inserted it into the pIRES2-EGFP vector to construct the pIRES2-MLAA34-HSP70 recombinant vector. We amplified the fusion gene MLAA34-HSP70 successfully and identified the correctness of pIRES2-MLAA34-HSP70 recombinant vector by PCR and restriction endonuclease. Moreover, the MLAA34-HSP70 recombinant proteins expressed in E. coli were consistent with the expected molecular weight. We constructed the pIRES2-MLAA34-HSP70 recombinant vector successfully and the MLAA34-HSP70 recombinant proteins were successfully expressed by the induction of IPTG
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Reacción en Cadena de la Polimerasa / Vacunas de ADN / Fusión Artificial Génica / Escherichia coli / Proteínas Reguladoras de la Apoptosis / Fusión Génica / Antígenos de Neoplasias Idioma: Inglés Revista: Pak. J. Pharm. Sci. Año: 2017

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Reacción en Cadena de la Polimerasa / Vacunas de ADN / Fusión Artificial Génica / Escherichia coli / Proteínas Reguladoras de la Apoptosis / Fusión Génica / Antígenos de Neoplasias Idioma: Inglés Revista: Pak. J. Pharm. Sci. Año: 2017